BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1438931)

  • 1. Glass yttrium-90 microspheres for patients with colorectal liver metastases.
    Anderson JH; Goldberg JA; Bessent RG; Kerr DJ; McKillop JH; Stewart I; Cooke TG; McArdle CS
    Radiother Oncol; 1992 Oct; 25(2):137-9. PubMed ID: 1438931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up.
    Andrews JC; Walker SC; Ackermann RJ; Cotton LA; Ensminger WD; Shapiro B
    J Nucl Med; 1994 Oct; 35(10):1637-44. PubMed ID: 7931662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yttrium 90 microsphere selective internal radiation treatment of hepatic colorectal metastases.
    Price TJ; Townsend A
    Arch Surg; 2008 Mar; 143(3):313-4. PubMed ID: 18347282
    [No Abstract]   [Full Text] [Related]  

  • 4. An experimental study and clinical pilot trials on yttrium-90 glass microspheres through the hepatic artery for treatment of primary liver cancer.
    Yan ZP; Lin G; Zhao HY; Dong YH
    Cancer; 1993 Dec; 72(11):3210-5. PubMed ID: 8242543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastases.
    Stubbs RS; Cannan RJ; Mitchell AW
    J Gastrointest Surg; 2001; 5(3):294-302. PubMed ID: 11360053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic metastases--a physiological approach to treatment.
    Chamberlain MN; Gray BN; Heggie JC; Chmiel RL; Bennett RC
    Br J Surg; 1983 Oct; 70(10):596-8. PubMed ID: 6626920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results.
    Murthy R; Xiong H; Nunez R; Cohen AC; Barron B; Szklaruk J; Madoff DC; Gupta S; Wallace MJ; Ahrar K; Hicks ME
    J Vasc Interv Radiol; 2005 Jul; 16(7):937-45. PubMed ID: 16002501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicentric phase II clinical trial on intra-arterial hepatic radiotherapy with 90yttrium SIR-spheres in unresectable, colorectal liver metastases refractory to i.v. chemotherapy: preliminary results on toxicity and response rates.
    Mancini R; Carpanese L; Sciuto R; Pizzi G; Golfieri R; Giampalma L; Cappelli A; Galaverni MC; Blotta A; Fiore F; Izzo F; Lastoria S; Mastro A; Di Marzo M; Cagol PP; Gasparini D; Geatti O; Bacchetti S; Pasqual E; Zeuli M; Paoletti G; Garufi C; Cosimelli M;
    In Vivo; 2006; 20(6A):711-4. PubMed ID: 17203751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic use of 90Y microspheres.
    Ehrhardt GJ; Day DE
    Int J Rad Appl Instrum B; 1987; 14(3):233-42. PubMed ID: 3667306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective internal radiation therapy (SIRT) with 90Yttrium microspheres for extensive colorectal liver metastases.
    Stubbs RS; Cannan RJ; Mitchell AW
    Hepatogastroenterology; 2001; 48(38):333-7. PubMed ID: 11379303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective internal radiation therapy: distribution of radiation in the liver.
    Burton MA; Gray BN; Klemp PF; Kelleher DK; Hardy N
    Eur J Cancer Clin Oncol; 1989 Oct; 25(10):1487-91. PubMed ID: 2591440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging.
    Lewandowski RJ; Thurston KG; Goin JE; Wong CY; Gates VL; Van Buskirk M; Geschwind JF; Salem R
    J Vasc Interv Radiol; 2005 Dec; 16(12):1641-51. PubMed ID: 16371530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant insulinomas with hepatic metastases successfully treated with selective internal radiation therapy.
    Ho KW; Wong CC; Balalla B; Diamond T
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):410-1. PubMed ID: 16918967
    [No Abstract]   [Full Text] [Related]  

  • 14. Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres.
    Mulcahy MF; Lewandowski RJ; Ibrahim SM; Sato KT; Ryu RK; Atassi B; Newman S; Talamonti M; Omary RA; Benson A; Salem R
    Cancer; 2009 May; 115(9):1849-58. PubMed ID: 19267416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Liver cirrhosis as sequela of selective hepatic radio-embolization with Yttrium (Y-90) microspheres].
    Brock H; Günther RW; Haage P
    Rofo; 2006 May; 178(5):546-8. PubMed ID: 16703491
    [No Abstract]   [Full Text] [Related]  

  • 16. Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors.
    Sarfaraz M; Kennedy AS; Cao ZJ; Sackett GD; Yu CX; Lodge MA; Murthy R; Line BR; Van Echo DA
    Med Phys; 2003 Feb; 30(2):199-203. PubMed ID: 12607837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete eradication of hepatic metastasis from colorectal cancer by Yttrium-90 SIRT.
    Garrean S; Muhs A; Bui JT; Blend MJ; Owens C; Helton WS; Espat NJ
    World J Gastroenterol; 2007 Jun; 13(21):3016-9. PubMed ID: 17589957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic malignancies: improved treatment with intraarterial Y-90.
    Herba MJ; Illescas FF; Thirlwell MP; Boos GJ; Rosenthall L; Atri M; Bret PM
    Radiology; 1988 Nov; 169(2):311-4. PubMed ID: 3174978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases.
    Cosimelli M; Golfieri R; Cagol PP; Carpanese L; Sciuto R; Maini CL; Mancini R; Sperduti I; Pizzi G; Diodoro MG; Perrone M; Giampalma E; Angelelli B; Fiore F; Lastoria S; Bacchetti S; Gasperini D; Geatti O; Izzo F;
    Br J Cancer; 2010 Jul; 103(3):324-31. PubMed ID: 20628388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study.
    Hickey R; Lewandowski RJ; Prudhomme T; Ehrenwald E; Baigorri B; Critchfield J; Kallini J; Gabr A; Gorodetski B; Geschwind JF; Abbott A; Shridhar R; White SB; Rilling WS; Boyer B; Kauffman S; Kwan S; Padia SA; Gates VL; Mulcahy M; Kircher S; Nimeiri H; Benson AB; Salem R
    J Nucl Med; 2016 May; 57(5):665-71. PubMed ID: 26635340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.